Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging

References

• Stewart FA. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl 1986;7:280–91.
   PubMedGoogle Scholar
• Lundbeck F, Sjogren C. A pharmacological in vitro study of the mouse urinary bladder at the time of acute change in bladder reservoir function after irradiation. J Urol 1992;148:179–82.
   PubMed Web of Science ®Google Scholar
• Lundbeck F, Ulso N, Overgaard J. Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder. Radioth Oncol 1989;15:383–92.
   PubMed Web of Science ®Google Scholar
• Rubin P, Wasserman TH. International clinical trials in radiation oncology. The late effects of toxicity scoring. Int J Rad Oncol Biol Phys 1988;14:29–38.
   Google Scholar
• Hueper WC. Experimental studies in cardiovascular pathology: V. Effects of intravenous injections of solutions of gum arabic, egg albumin and gelatin upon the blood and organs of dogs and rabbits. Am J Pathol 1942;18:895–933.
   PubMedGoogle Scholar
• Rosen S, Peters CA, Chevalier RL, Huang WY. The kidney in congenital ureteropelvic junction obstruction: a spectrum from normal to nephrectomy. J Urol 2008;179:1257–63.
   PubMed Web of Science ®Google Scholar
• Schreiber H, Oehlert W, Kugler K. Regeneration and proliferation kinetics of normal and X-irradiated transitional epithelium in the rat. Virchows Arch B Cell Pathol 1969;4:30–44.
   PubMedGoogle Scholar
• Kagan AR. Bladder, testicle, and prostate irradiation injury. Front Radiat Ther Oncol 1989;23:323–37.
   PubMedGoogle Scholar
• Bentzen SM, Thames HD. Overall treatment time and tumor control dose for head and neck tumors: the dog leg revisited. Radioth Oncol 1992;25:143–4.
   PubMed Web of Science ®Google Scholar
• Thames HD, Jr, Rozell ME, Tucker SL, Ang KK, Fisher DR, Travis EL. Direct analysis of quantal radiation response data. Int J Radiat Biol Relat Stud Phys Chem Med. 1986;49:999–1009.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based. Radiother Oncol 2005;77:227–30.
   PubMed Web of Science ®Google Scholar
• Habermehl D, Naumann P, Bendl R, Oelfke U, Nill S, Debus J, et al. Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial. Rad Oncol 2015;10:143–4.
   PubMed Web of Science ®Google Scholar
• Rödel C, Weiss C, Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 2006;24:5536–44.
   PubMed Web of Science ®Google Scholar
• Rödel C, Grabenbauer GG, Kuhn R, Papadopoulos T, Dunst J, Meyer M, et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002;20:3061–71.
   PubMed Web of Science ®Google Scholar
• Weiss C, Sauer R, Rödel C. Radiochemotherapeutic options for bladder cancer. Aktuelle Urol 2008;39:123–9.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1997;37:259–67.
   PubMed Web of Science ®Google Scholar
• De Neve W, Lybeert ML, Goor C, Crommelin MA, Ribot JG. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother Oncol 1995;36:183–8.
   PubMed Web of Science ®Google Scholar
• Mameghan H, Fisher R, Mameghan J, Brook S. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 1995;31:247–54.
   PubMed Web of Science ®Google Scholar
• Weiss C, Engehausen DG, Krause FS, Papadopoulos T, Dunst J, Sauer R, et al. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer. Int J Radiat Oncol Biol Phys 2007;68:1072–80.
   PubMed Web of Science ®Google Scholar
• Ott OJ, Rödel C, Weiss C, Wittlinger M, St Krause F, Dunst J, et al. Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol). 2009;21:557–65.
   PubMed Web of Science ®Google Scholar
• Oh KS, Soto DE, Smith DC, Montie JE, Lee CT, Sandler HM. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys 2009;74:511–17.
   PubMed Web of Science ®Google Scholar
• Nichols RC Jr, Sweetser MG, Mahmood SK, Malamud FC, Dunn NP, Adams JP, et al. Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination. Int J Cancer 2000;90:281–6.
   PubMed Web of Science ®Google Scholar
• Dunst J, Weigel C, Heynemann H, Becker A. Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer. Strahlenther Onkol 1999;175:7–10.
   PubMed Web of Science ®Google Scholar
• Patel B, Forman J, Fontana J, Frazier A, Pontes E, Vaishampayan U. A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. Int J Radiat Oncol Biol Phys 2005;62:1332–8.
   PubMed Web of Science ®Google Scholar
• Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer 2008;44:2546–54.
   PubMed Web of Science ®Google Scholar
• Baronzio G, Gramaglia A, Fiorentini G. Hyperthermia and immunity. A brief overview. In Vivo 2006;20:689–95.
   PubMed Web of Science ®Google Scholar
• Jäättelä M. Effects of heat shock on cytolysis mediated by NK cells, LAK cells, activated monocytes and TNFs alpha and beta. Scand J Immunol 1990;31:175–82.
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007;82:1322–31.
   PubMed Web of Science ®Google Scholar
• Dayanc BE, Beachy SH, Ostberg JR, Repasky EA. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 2008;24:41–56.
   PubMed Web of Science ®Google Scholar
• Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 1997;158:4341–50.
   PubMed Web of Science ®Google Scholar
• Wong JY, Mivechi NF, Paxton RJ, Williams LE, Beatty BG, Beatty JD, et al. The effects of hyperthermia on tumor carcinoembryonic antigen expression. Int J Radiat Oncol Biol Phys 1989;17:803–8.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Mitsuhashi N, Sakurai H, Niibe H. Modifications of tumor-associated antigen expression on human lung cancer cells by hyperthermia and cytokine. Anticancer Res 1995;15:2601–6.
   PubMed Web of Science ®Google Scholar
• Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, et al. Hyperthermia enhances CTL cross-priming. J Immunol 2006;176:2134–41.
   PubMed Web of Science ®Google Scholar
• Multhoff G. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 2007;43:229–37.
   PubMed Web of Science ®Google Scholar
• Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 2005;65:5238–47.
   PubMed Web of Science ®Google Scholar
• Bayer C, Liebhardt ME, Schmid TE, Trajkovic-Arsic M, Hube K, Specht HM, et al. Validation of heat shock protein 70 as a tumor-specific biomarker for monitoring the outcome of radiation therapy in tumor mouse models. Int J Radiat Oncol Biol Phys 2014;88:694–700.
   PubMed Web of Science ®Google Scholar
• Breuninger S, Erl J, Knape C, Gunther S, Regel I, Rödel F, et al. Quantitative analysis of liposomal heat shock protein 70 (Hsp70) in the blood of tumor patients using a novel LipHsp70 ELISA. Clin Cellular Immunol 2014;5:2–10.
   Google Scholar
• Gehrmann M, Cervello M, Montalto G, Cappello F, Gulino A, Knape C, et al. Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Front Immunol 2014;5:e307.
   PubMed Web of Science ®Google Scholar
• Davies CD, Lindmo T. Hyperthermia-induced shedding and masking of melanoma-associated antigen. Int J Hyperthermia 1990;6:1053–64.
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother 2006;55:312–19.
   PubMed Web of Science ®Google Scholar
• Blom DJ, De Waard-Siebinga I, Apte RS, Luyten GP, Niederkorn JY, Jager MJ. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines. Melanoma Res 1997;7:103–9.
   PubMed Web of Science ®Google Scholar
• Dressel R, Elsner L, Quentin T, Walter L, Günther E. Heat shock protein 70 is able to prevent heat shock-induced resistance of target cells to CTL. J Immunol 2000;164:2362–71.
   PubMed Web of Science ®Google Scholar
• Pepin E, Villiers CL, Gabert FM, Serra VA, Marche PN, Colomb MG. Heat shock increases antigenic peptide generation but decreases antigen presentation. Eur J Immunol 1996;26:2939–43.
   PubMed Web of Science ®Google Scholar
• Kuperberg G, Ellis J, Marcinkiewicz J, Chain BM. Temperature-induced stress abrogates co-stimulatory function in antigen-presenting cells. Eur J Immunol 1991;21:2791–5.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, Guha C. Hyperthermia on immune regulation: a temperature’s story. Cancer Lett 2008;271:191–204.
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Kabingu E, Repasky EA. Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia 2003;19:520–33.
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Clancy KA, Gauguet JM, Wang WC, Unger E, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 2006;7:1299–308.
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Kucinska SA, Wang WC, Evans SS. Dynamic control of lymphocyte trafficking by fever-range thermal stress. Cancer Immunol Immunother 2006;55:299–311.
   PubMed Web of Science ®Google Scholar
• Zhang JM, Wu XH, Zhang Y, Xia YG, Luo CL. Exosomes derived form bladder transitional cell carcinoma cells induce CTL cytotoxicity in vitro. Zhonghua Zhong Liu Za Zhi [Chinese J Oncol] 2009;31:738–41.
   PubMedGoogle Scholar
• Shevach EM. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389–400.
   PubMed Web of Science ®Google Scholar
• Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Cur Opin Immunol 2003;15:690–6.
   PubMed Web of Science ®Google Scholar
• Lee MK, Moore DJ, Jarrett BP, Lian MM, Deng S, Huang X, et al. Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004;172:6539–44.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann Rev Immunol 2004;22:531–62.
   PubMed Web of Science ®Google Scholar
• Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387–96.
   PubMed Web of Science ®Google Scholar
• Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212–18.
   PubMed Web of Science ®Google Scholar
• Nelson BH. IL-2, regulatory T cells, and tolerance. J Immunol 2004;172:3983–8.
   PubMed Web of Science ®Google Scholar
• Golgher D, Jones E, Powrie F, Elliott T, Gallimore A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002;32:3267–75.
   PubMed Web of Science ®Google Scholar
• Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823–32.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151–64.
   PubMed Web of Science ®Google Scholar
• Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 1999;59:3128–33.
   PubMed Web of Science ®Google Scholar
• Steitz J, Bruck J, Lenz J, Knop J, Tuting T. Depletion of CD25+CD4+ T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8+ T-cell-dependent immune defense of B16 melanoma. Cancer Res 2001;61:8643–6.
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9:606–12.
   PubMed Web of Science ®Google Scholar
• Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, et al. CD4+CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J Immunol 2003;171:5931–9.
   PubMed Web of Science ®Google Scholar
• Antony PA, Piccirillo CA, Akpinarli A, Finkelstein SE, Speiss PJ, Surman DR, et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 2005;174:2591–601.
   PubMed Web of Science ®Google Scholar
• Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, et al. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol 2006;13:1252–8.
   PubMed Web of Science ®Google Scholar
• Rudge G, Barrett SP, Scott B, van Driel IR. Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells. J Immunol 2007;178:4089–96.
   PubMed Web of Science ®Google Scholar
• Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265(5171):528–30.
   PubMed Web of Science ®Google Scholar
• Cippitelli M, Fionda C, Di Bona D, Piccoli M, Frati L, Santoni A. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J Immunol 2005;174:223–32.
   PubMed Web of Science ®Google Scholar
• Ma L, Sato F, Sato R, Matsubara T, Hirai K, Yamasaki M, et al. Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer. Oncol Rep 2014;31:2482–92.
   PubMed Web of Science ®Google Scholar
• Ljunggren HG, Kärre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990;11:237–44.
   PubMedGoogle Scholar
• Biassoni R. Human natural killer receptors, co-receptors, and their ligands. Curr Protoc Immunol 2009;14:Unit 14.10.
   PubMedGoogle Scholar
• Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, et al. A stress-inducible Hsp is expressed on the cell surface of human Tumor but not on normal cells. Int J Can 1995;61:272–279.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Schmetzer H, Eissner G, Haferlach T, Hiddemann W, Multhoff G. Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 2003;88:474–6.
   PubMed Web of Science ®Google Scholar
• Falguieres T, Maak M, von Weyhern C, Sarr M, Sastre X, Poupon MF, et al. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther 2008;7:2498–508.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, De Maio A, et al. Tumor-specific Hsp70 plasma membrane localization is enabled by the glycophospholipid Gb3. PLoS One. 2008;3:e1925.
   PubMed Web of Science ®Google Scholar
• Mise K, Kan N, Okino T, Nakanishi M, Satoh K, Teramura Y, et al. Effect of heat treatment on tumor cells and antitumor effector cells. Cancer Res 1990;50:6199–202.
   PubMed Web of Science ®Google Scholar
• Wells AD, Malkovsky M. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today 2000;21:129–32.
   PubMedGoogle Scholar
• Ménoret A, Patry Y, Burg C, Le Pendu J. Co-segregation of tumor immunogenicity with expression of inducible but not constitutive Hsp70 in rat colon carcinomas. J Immunol 1995;155:740–7.
   PubMed Web of Science ®Google Scholar
• Gross C, Hansch D, Gastpar R, Multhoff G. Interaction of Hsp70 Peptide with NK cells involves the NK cell receptor CD94. Biol Chem 2003;383:267–279.
   Google Scholar
• Elsner L, Muppala V, Gehrmann M, Lozano J, Malzahn D, Bickeboller H, et al. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands. J Immunol 2007;179:5523–33.
   PubMed Web of Science ®Google Scholar
• Elsner L, Flügge PF, Lozano J, Muppala V, Eiz-Vesper B, Demiroglu SY, et al. The endogenous danger signals Hsp70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med 2009;14:992–1002.
   Web of Science ®Google Scholar
• Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549–55.
   PubMed Web of Science ®Google Scholar
• Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007;131:463–75.
   PubMed Web of Science ®Google Scholar
• Scotton C, Milliken D, Wilson J, Raju S, Balkwill F. Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer 2001;85:891–7.
   PubMed Web of Science ®Google Scholar
• Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625–9.
   PubMed Web of Science ®Google Scholar
• Onita T, Ji PG, Xuan JW, Sakai H, Kanetake H, Maxwell PH, et al. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin Cancer Res 2002;8:471–80.
   PubMed Web of Science ®Google Scholar
• Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002;440:583–8.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kB and enhanced IRF-3/STAT1 activation). Blood 2006;107:2112–22.
   PubMed Web of Science ®Google Scholar
• Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, et al. p50 nuclear factor-kB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006;66:11432–40.
   PubMed Web of Science ®Google Scholar
• Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006;80:1183–96.
   PubMed Web of Science ®Google Scholar
• Kubes J, Svoboda J, Rosina J, Starec M, Fiserova A. Immunological response in the mouse melanoma model after local hyperthermia. Physiol Res 2008;57:459–65.
   PubMed Web of Science ®Google Scholar
• van Note S, Kisailus A, Hylander B, Ostberg J, Evans S, Repasky E. The effects of fever-range whole body hyperthermia on macrophage infiltration in tumors. World Conference on Interventional Oncology, Los Angeles, CA, 2007, p. 31.
   Google Scholar
• Ivarsson K, Myllymaki L, Jansner K, Bruun A, Stenram U, Tranberg KG. Heat shock protein 70 (Hsp70) after laser thermotherapy of an adenocarcinoma transplanted into rat liver. Anticancer Res 2003;23:3703–12.
   PubMed Web of Science ®Google Scholar
• Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004;104:2224–34.
   PubMed Web of Science ®Google Scholar
• Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999;79:991–5.
   PubMed Web of Science ®Google Scholar
• Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 2004;24:3335–42.
   PubMed Web of Science ®Google Scholar
• Negus RP, Stamp GW, Hadley J, Balkwill FR. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 1997;150:1723–34.
   PubMed Web of Science ®Google Scholar
• Bailey C, Negus R, Morris A, Ziprin P, Goldin R, Allavena P, et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 2007;24:121–30.
   PubMed Web of Science ®Google Scholar
• Li C, Shintani S, Terakado N, Nakashiro K, Hamakawa H. Infiltration of tumor-associated macrophages in human oral squamous cell carcinoma. Oncol Rep 2002;9:1219–23.
   PubMed Web of Science ®Google Scholar
• Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000;157:411–21.
   PubMed Web of Science ®Google Scholar
• Lewis C, Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 2005;167:627–35.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim SH, Hahn EW, Song CW. 5-thio-D-glucose selectively potentiates hyperthermic killing of hypoxic tumor cells. Science 1978;200(4338):206–7.
   PubMed Web of Science ®Google Scholar
• Herman TS, Teicher BA, Chan V, Collins LS, Abrams MJ. Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 1989;16:443–9.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Radons J, Molls M, Multhoff G. The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 2008;13:1–10.
   PubMed Web of Science ®Google Scholar
• Stangl S, Gehrmann M, Riegger J, Kuhs K, Riederer I, Sievert W, et al. Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. Proc Natl Acad Sci USA 2011;108:733–8.
   PubMed Web of Science ®Google Scholar
• Stangl S, Themelis G, Friedrich L, Ntziachristos V, Sarantopoulos A, Molls M, et al. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment. Radiother Oncol 2011;99:313–16.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Stangl S, Foulds GA, Oellinger R, Breuninger S, Rad R, et al. Tumor imaging and targeting potential of an Hsp70-derived 14-mer peptide. PLoS ONE 2014;9:e105344.
   PubMed Web of Science ®Google Scholar
• Stangl S, Varga J, Freysoldt B, Trajkovic-Arsic M, Siveke JT, Greten FR, et al. Selective in vivo imaging of syngeneic, spontaneous, and xenograft tumors using a novel tumor cell-specific hsp70 peptide-based probe. Cancer Res 2014;74:6903–12.
   PubMed Web of Science ®Google Scholar
• Trajkovic-Arsic M, Mohajerani P, Sarantopoulos A, Kalideris E, Steiger K, Esposito I, et al. Multimodal molecular imaging of integrin alpha v beta 3 for in vivo detection of pancreatic cancer. J Nucl Med 2014;55:446–51.
   PubMed Web of Science ®Google Scholar
• Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Luckerath K, et al. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med 2015;7:477–87.
   PubMed Web of Science ®Google Scholar
• de Martino M, Lucca I, Mbeutcha A, Wiener HG, Haitel A, Susani M, et al. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. Eur Urol 2015;68:552–4.
   PubMed Web of Science ®Google Scholar
• Aoun F, Kourie HR, Artigas C, Roumeguere T. Next revolution in molecular theranostics: personalized medicine for urologic cancers. Future Oncol 2015;11:2205–19.
   PubMed Web of Science ®Google Scholar
• Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, et al. Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma. PLoS ONE 2015;10:e0131245.
   PubMed Web of Science ®Google Scholar
• Gorin MA, Rowe SP, Allaf ME. Nuclear imaging of renal tumours: a step towards improved risk stratification. Nature Rev Urol 2015;12:445–50.
   PubMed Web of Science ®Google Scholar
• Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegård J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003;42:235–8.
   PubMed Web of Science ®Google Scholar
• Kocsis J, Madaras B, Toth EK, Fust G, Prohaszka Z. Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress Chaperones 2009;15:143–51.
   PubMed Web of Science ®Google Scholar
• Wang MH, Grossmann ME, Young CY. Forced expression of heat shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth. Br J Cancer 2004;90:926–31.
   PubMed Web of Science ®Google Scholar
• Margel D, Pevsner-Fischer M, Baniel J, Yossepowitch O, Cohen IR. Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol 2011;59:113–19.
   PubMed Web of Science ®Google Scholar
• Yu HJ, Chang YH, Pan CC. Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder. Histopathol 2013;62:788–98.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010;11:561–70.
   PubMed Web of Science ®Google Scholar
• Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 2008;70:1176–82.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995;345(8949):540–3.
   PubMed Web of Science ®Google Scholar
• Colombo R, Da Pozzo LF, Salonia A, Rigatti P, Leib Z, Baniel J, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003;21:4270–6.
   PubMed Web of Science ®Google Scholar
• Wittlinger M, Rödel CM, Weiss C, Krause SF, Kuhn R, Fietkau R, et al. Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009;93:358–63.
   PubMed Web of Science ®Google Scholar
• Geijsen ED, de Reijke TM, Koning CC, Zum Vorde Sive Vording PJ, de la Rosette JJ, Rasch CR, et al. Combining mitomycin C and regional 70 MHz hyperthermia in patients with non-muscle invasive bladder cancer: a pilot study. J Urol 2015;194:1202–8.
   PubMed Web of Science ®Google Scholar
• Crezee J, Van Haaren PM, Westendorp H, De Greef M, Kok HP, Wiersma J, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: a preclinical study. Int J Hyperthermia 2009;25:581–92.
   PubMed Web of Science ®Google Scholar
• Song C, Park HJ, Lee CK, Griffin R. Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005;21:761–8.
   PubMed Web of Science ®Google Scholar
• Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008;24:251–61.
   PubMed Web of Science ®Google Scholar
• Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, et al. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:176–83.
   PubMed Web of Science ®Google Scholar
• Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5.
   PubMed Web of Science ®Google Scholar
• Sousa A, Inman BA, Pineiro I, Monserrat V, Perez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:166–70.
   PubMed Web of Science ®Google Scholar
• Issels RD. High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy. Int J Hyperthermia 2006;22:235–9.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Kuwano H, Watnabe M, Nozoe T, Yasuda M, Sumiyoshi K, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995;60:55–8.
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 1996;35:731–44.
   PubMed Web of Science ®Google Scholar
• Shchepotin IB, Evans SR, Chorny V, Osinsky S, Buras RR, Maligonov P, et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol 1994;3:37–44.
   PubMed Web of Science ®Google Scholar
• Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Rad Oncol Biol Phys 2005;61:145–53.
   PubMed Web of Science ®Google Scholar
• Demaria S, Golden EB, Formenti SC. Role of local radiation therapy in cancer immunotherapy. JAMA Oncol 2015;1:1325–32.
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Can Immunol Res 2013;1:210–16.
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9.
   PubMed Web of Science ®Google Scholar